Biotimize is a Brazilian Contract Development and Manufacturing Organisation (CDMO) that offers personalised biotechnology and bioprocess engineering-based services for preclinical and clinical studies to global biopharmaceutical companies. With a mission to transform lives through biotechnology, Biotimize enables ideas, treatments, and dreams to become reality while driving new regulatory models that prioritise innovation. The company strives to develop new approaches to democratise access to science and healing, creating a positive impact on people’s lives.

Services include:
– Biologics
– Cell Line Development
– Process Development and Optimization
– Bioproduction
– Analytics Development
– Technical-Economic Analysis
– PoC material production
– Preclinical material production
– Clinical material production

Biotimize Biotechnology as a Service aims to empower the pharmaceutical industry with its comprehensive suite of offerings. For more information, visit biotimize.com.br.